Close Menu

layoffs

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The past year saw several high-profile firms in the genomics tools and molecular diagnostics industries undertake restructurings and/or layoffs amid challenging economic conditions.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – SQI Diagnostics announced after the close of the market on Wednesday that it is restructuring its business to focus on its Diagnostics Tools and Services business.

Qiagen reported after the close of the market Monday that it will cut between 8 percent and 10 percent of its global workforce in a reorganization intended to improve efficiency and resource allocation.

Thermo Fisher Scientific has reduced its headcount by about 890 through the first nine months of the year, including 450 during the third quarter, it disclosed in it quarterly earnings document filed today with the US Securities and Exchange Commission.

This story was originally published Oct. 26.

Illumina filed a document with the US Securities and Exchange Commission disclosing that it will cut 200 jobs from its global workforce.

Pages

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.